- https://jobcopusa.com/employer/anadrol-bodybuilding-forum/
-
Survodutide completed separate phase 2 trials in 2024 examining individuals with obesity and those with biopsy confirmed MASH. Weight loss ranged from 9.5% at 1mg to 16.4% at the 9mg dose.
- Joined on
2026-04-01
No matching repositories found.